Cardiac Defibrillators

Global Cardiac Defibrillators Market to Reach US$22.9 Billion by 2030

The global market for Cardiac Defibrillators estimated at US$14.5 Billion in the year 2024, is expected to reach US$22.9 Billion by 2030, growing at a CAGR of 7.9% over the analysis period 2024-2030. Implantable / Internal Cardiac Defibrillator, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$12.3 Billion by the end of the analysis period. Growth in the External Cardiac Defibrillator segment is estimated at 10.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.9 Billion While China is Forecast to Grow at 7.5% CAGR

The Cardiac Defibrillators market in the U.S. is estimated at US$3.9 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.6 Billion by the year 2030 trailing a CAGR of 7.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.8% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.2% CAGR.

Global Cardiac Defibrillators Market - Key Trends and Drivers Summarized

Cardiac defibrillators are essential medical devices used to treat cardiac arrhythmias, especially ventricular fibrillation and ventricular tachycardia. Several significant factors drive the growth of the cardiac defibrillator market. The increasing prevalence of cardiovascular diseases (CVDs), such as heart attacks and strokes, significantly boosts demand for defibrillators. The World Health Organization identifies CVDs as the leading cause of death worldwide. Technological advancements also play a critical role, with innovations like wireless connectivity, remote monitoring, and more compact designs making defibrillators increasingly effective and user-friendly. The latest implantable devices offer better longevity and improved data reporting.

The growing geriatric population, which is more susceptible to CVDs, requires advanced healthcare solutions, further fueling the demand for defibrillators. In addition, awareness and training programs that promote the use of defibrillators, especially automated external defibrillators (AEDs), increase accessibility to these life-saving devices in public spaces. Government initiatives and funding support their adoption across healthcare facilities, while rising investments in healthcare infrastructure and growing awareness in emerging markets such as Asia-Pacific and Latin America spur growth.

The integration of Artificial Intelligence (AI) and the Internet of Things (IoT) into defibrillators enables predictive maintenance, real-time monitoring, and connectivity. Artificial Intelligence (AI) significantly impacts how defibrillators work, making them more efficient through machine learning algorithms that enhance life-saving treatments.  Wearable defibrillators have become popular as non-invasive, temporary solutions for patients awaiting implantable devices. Subcutaneous implantable defibrillators (S-ICD) are gaining traction because of their less invasive nature, which reduces infection risk. Additionally, smart monitoring enables continuous, real-time patient monitoring and data sharing with healthcare providers.

SCOPE OF STUDY:

The report analyzes the Cardiac Defibrillators market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product Segment (Implantable / Internal Cardiac Defibrillator, External Cardiac Defibrillator); End-Use (Hospitals, Public Access, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 48 Featured) -

• Abbott Laboratories
• Biotronik GmbH & Co. KG
• Boston Scientific Corporation
• Cardiac Science Corporation
• GE Healthcare Ltd.
• Medtronic, Inc.
• Philips Healthcare
• Physio-Control Inc.
• St. Jude Medical Inc.
• Zoll Medical Corporation

AI INTEGRATIONS
We`re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.